Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $205
Investment winter under Trump's tariffs: Shareholders of Novo-Nordisk A/S slow down expansion plans.
① The major shareholder of Novo-Nordisk A/S, Novo Holdings, will slow down investment activities due to increased economic uncertainty from President Trump's tariffs; ② Although Trump's policies conflict with the values of Novo Holdings, the company does not plan to exit the USA market and is considering entering the defense and nuclear energy sectors.
Medicus Pharma To Acquire Antev Ltd. For 19% Equity Stake, Or ~2.67M Shares, With Potential $65M In Milestone Payments For Prostate Drug Teverelix
Scribe Therapeutics And Prevail To Present New Preclinical Data On SiXAAV Technology From Collaboration At ASGCT Annual Meeting
This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday
Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $250